Immunopathologies encompass a range of conditions known for their defined pathophysiology but lack safe and effective treatment options. These diseases impact an estimated 3-5% of the global population. Current treatments, while partially effective, often come with high toxicity and require long-term administration; these include corticosteroids, NSAIDs, and monoclonal antibodies. Frequent adverse reactions from these drugs significantly impact patient compliance and overall treatment success. This highlights a critical need for innovative therapeutic approaches that promise lower toxicity and enhanced efficacy.
This Research Topic aims to highlight and address the significant gaps in safe treatment options for immune-mediated diseases. By focusing on the development of non-steroidal molecules that target specific biological pathways, this research hopes to uncover new chemical entities that are capable of altering disease progression. The discovery of these novel agents could transform treatment paradigms, leading to improved patient outcomes and life expectancy.
To enhance our understanding and accelerate the development of innovative treatments, this Research Topic will serve as a platform dedicated to the following aspects, though not exclusive:
- Exploring the heterogeneity within inflammatory diseases
- Discussing challenges and emerging trends in anti-inflammatory drug development
- Assessing the clinical predictivity of experimental models in inflammatory diseases
- Strategies for improving treatments for inflammation
- Researchers are encouraged to contribute original research, systematic reviews, mini-reviews, data reports, and opinion pieces to explore these themes comprehensively.
Immunopathologies encompass a range of conditions known for their defined pathophysiology but lack safe and effective treatment options. These diseases impact an estimated 3-5% of the global population. Current treatments, while partially effective, often come with high toxicity and require long-term administration; these include corticosteroids, NSAIDs, and monoclonal antibodies. Frequent adverse reactions from these drugs significantly impact patient compliance and overall treatment success. This highlights a critical need for innovative therapeutic approaches that promise lower toxicity and enhanced efficacy.
This Research Topic aims to highlight and address the significant gaps in safe treatment options for immune-mediated diseases. By focusing on the development of non-steroidal molecules that target specific biological pathways, this research hopes to uncover new chemical entities that are capable of altering disease progression. The discovery of these novel agents could transform treatment paradigms, leading to improved patient outcomes and life expectancy.
To enhance our understanding and accelerate the development of innovative treatments, this Research Topic will serve as a platform dedicated to the following aspects, though not exclusive:
- Exploring the heterogeneity within inflammatory diseases
- Discussing challenges and emerging trends in anti-inflammatory drug development
- Assessing the clinical predictivity of experimental models in inflammatory diseases
- Strategies for improving treatments for inflammation
- Researchers are encouraged to contribute original research, systematic reviews, mini-reviews, data reports, and opinion pieces to explore these themes comprehensively.